DKSH stock expands Asia deal as half-year sales rise 4.9 percent

DKSH stock is extending its healthcare platform after a Grunenthal agreement covering four medicines across eight Asia-Pacific markets. The partnership was announced on September 28, 2026, while DKSH's first-half results showed net sales up 4.9 percent to CHF 5.5 billion.

Healthcare deal reaches eight markets

According to Grunenthal on September 28, 2026, DKSH will commercialize Qutenza, Vimovo, Palexia and Zomig in Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam, subject to local regulatory approvals. DKSH will handle local marketing authorizations, market access, sales, marketing and distribution.

The agreement gives the Healthcare business a wider commercialization role rather than a single-market distribution mandate. That matters because management identified healthcare outsourcing as a central growth area in the first half, with new contracts requiring upfront investment before their revenue contribution scales.

Sales accelerate while margin holds

In the H1 2026 earnings call, Yahoo Finance reported that Core EBIT increased 3.6 percent to CHF 163.4 million, while Core EBIT margin stood at 3.0 percent. Adjusted earnings per share rose 10.6 percent to CHF 1.56, and free cash flow reached CHF 147.7 million in the six months ended June 30, 2026.

The comparison is constructive but not uniform: sales growth exceeded Core EBIT growth by 1.3 percentage points, while the margin was 10 basis points below the first-half 2025 level. Management attributed the pressure to foreign-exchange translation, channel mix and investments supporting new healthcare contracts.

Berenberg cuts target to CHF 68

According to Investing.com, Berenberg downgraded DKSH to Hold from Buy on August 25, 2026 and cut its price target from CHF 75.00 to CHF 68.00. The same overview showed an eight-analyst average target of CHF 73.50, giving investors a clear split between the cautious single-house view and the broader consensus.

At the SIX Swiss Exchange, DKSH was last at CHF 69.50 on September 30, 2026 at 1:59 p.m. CEST. Its 52-week range was CHF 52.90 to CHF 69.90, and market capitalization stood at CHF 4.5 billion on September 30, 2026.